تقرير
أعرض في EDS

Beware of Rhabdomyolysis After a Renal Graft.

التفاصيل البيبلوغرافية
العنوان: Beware of Rhabdomyolysis After a Renal Graft.
المؤلفون: El Bardai G; Nephrology, Dialysis, and Transplantation, Hassan II University Hospital, Fez, MAR.; Laboratory of Epidemiology and Health Science Research (ERESS), Faculty of Medicine, Sidi Mohammed Ben Abdellah University, Fez, MAR., Chouhani BA; Nephrology, Dialysis, and Transplantation, Hassan II University Hospital, Fez, MAR.; Laboratory of Epidemiology and Health Science Research (ERESS), Faculty of Medicine, Sidi Mohammed Ben Abdellah University, Fez, MAR., Haddane W; Nephrology, Dialysis, and Transplantation, Hassan II University Hospital, Fez, MAR., Kabbali N; Nephrology, Dialysis, and Transplantation, Hassan II University Hospital, Fez, MAR.; Laboratory of Epidemiology and Health Science Research (ERESS), Faculty of Medicine, Sidi Mohammed Ben Abdellah University, Fez, MAR., Sqalli Houssaini T; Nephrology, Dialysis, and Transplantation, Hassan II University Hospital, Fez, MAR.; Laboratory of Epidemiology and Health Science Research (ERESS), Faculty of Medicine, Sidi Mohammed Ben Abdellah University, Fez, MAR.
المصدر: Cureus [Cureus] 2022 Oct 21; Vol. 14 (10), pp. e30546. Date of Electronic Publication: 2022 Oct 21 (Print Publication: 2022).
نوع المنشور: Case Reports
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: In recent years, there has been a significant advancement in the field of immunosuppressive therapy in renal transplantation. However, these treatments have side effects, including rhabdomyolysis. In this article, we report the case of a transplant patient with rhabdomyolysis secondary to tacrolimus and shed light on different aggravating factors. Treatment withdrawal, hydration, and forced diuresis are allowed in the majority of cases.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2022, El Bardai et al.)
References: Lancet. 1995 Sep 9;346(8976):702. (PMID: 7544861)
Saudi J Kidney Dis Transpl. 2011 May;22(3):521-4. (PMID: 21566311)
Transplant Proc. 2004 Jan-Feb;36(1):175-7. (PMID: 15013338)
Nervenarzt. 2003 Jun;74(6):505-15. (PMID: 12799789)
Ochsner J. 2015 Spring;15(1):58-69. (PMID: 25829882)
J Am Soc Nephrol. 2007 Nov;18(11):2870-4. (PMID: 17942960)
Transplantation. 2011 Jul 27;92(2):e8-9. (PMID: 21747275)
Cases J. 2009 Jul 07;2:6479. (PMID: 19829812)
Therapie. 2013 Mar-Apr;68(2):69-76. (PMID: 23773347)
Pharmacotherapy. 2021 Jan;41(1):119-131. (PMID: 33131123)
Transplant Proc. 2004 Apr;36(3):711-2. (PMID: 15110640)
Pharmgenomics Pers Med. 2021 Nov 19;14:1463-1474. (PMID: 34824543)
فهرسة مساهمة: Keywords: renal allograft; rhabdomyolysis; secondary effect; tacrolimus; toxicity
تواريخ الأحداث: Date Created: 20221123 Latest Revision: 20221124
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9676010
DOI: 10.7759/cureus.30546
PMID: 36415354
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.30546